ORAL PREMALIGNANT LESION

Clinical trials for ORAL PREMALIGNANT LESION explained in plain language.

Never miss a new study

Get alerted when new ORAL PREMALIGNANT LESION trials appear

Sign up with your email to follow new studies for ORAL PREMALIGNANT LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Genetically modified cells injected into mouth lesions to stop cancer before it starts

Disease control Not yet recruiting

This early-phase trial tests whether specially engineered immune cells (NK cells) can safely treat high-risk precancerous spots in the mouth. The cells are injected directly into the lesions and are designed to target a protein called TROP2, while also resisting signals that norm…

Matched conditions: ORAL PREMALIGNANT LESION

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

ORAL PREMALIGNANT LESION

Get alerted when new ORAL PREMALIGNANT LESION trials appear

Genetically modified cells injected into mouth lesions to stop cancer before it starts